{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:49:30Z","timestamp":1792014570362,"version":"4.4.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health","award":["AG045781"],"award-info":[{"award-number":["AG045781"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Alzheimer\u2019s disease (AD) and related dementias (ADRDs) remain incurable, partly due to their complex and poorly understood pathogenic mechanisms. Loss of vacuolar protein sorting-associated protein 35 (VPS35), a core component of the retromer complex, has been implicated in AD and ADRDs. While\n                      <jats:italic>Vps35<\/jats:italic>\n                      deficiency is known to increase amyloidogenesis by regulating its cargo proteins, such as APP and BACE1, the precise mechanism by which VPS35 dysfunction leads to cognitive impairment remains elusive. While neuronal VPS35 regulates trafficking and functions of\u00a0multiple synaptic membrane proteins, such as postsynaptic glutamatergic and GABAnergic receptors and pre-synaptic vesicle protein SV2A, and Levetiracetam (LEV), an antiepileptic drug that improves cognition, interacts with the SV2A, exactly how LEV enhances cognition is still a matter of debate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Given the abundant expression of VPS35 in pyramidal excitatory neurons, we generated a conditional knockout mouse model with\n                      <jats:italic>Vps35<\/jats:italic>\n                      deletion from postnatal glutamatergic excitatory neurons (\n                      <jats:italic>Vps35<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>CaMKII\u03b1<\/jats:italic>\n                      <\/jats:sup>\n                      ) and characterized its phenotypes using a combination of behavioral assessments, and electrophysiological, biochemical, and immunohiotological analyses in the hippocampal CA1 region. A targeted pharmacological screen was conducted to evaluate the therapeutic potential of LEV.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Vps35<\/jats:italic>\n                      deletion did not disrupt the gross brain development but led to progressive cognitive decline beginning at three months of age. Electrophysiological analyses revealed earlier-onset hippocampal CA1 hyperexcitability, marked by depolarized resting membrane potentials and reduced Kir\n                      <jats:sub>2.1<\/jats:sub>\n                      expression. However, restoring Kir\n                      <jats:sub>2.1<\/jats:sub>\n                      to suppress hyperexcitability failed to rescue cognitive deficits. Instead, cognitive impairment was associated with weakened GABAergic transmission and disruption of the excitatory\/inhibitory balance in the Schaffer collateral\u2013CA1 circuit. Notably, LEV treatment diminished these deficits in mutant mice. Intriguingly, LEV increased the levels of retromer component, VPS26A, and multiple pre- and postsynaptic GABAergic proteins, in addition to SV2A, all of which were reduced in\n                      <jats:italic>Vps35<\/jats:italic>\n                      -deficient CA1 neurons.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings identify VPS35 in excitatory neurons as a critical factor for inhibitory synapse maintenance and network homeostasis. This study also highlights LEV as a potential therapeutic strategy for ADRDs through the preservation of GABAergic synapses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40035-026-00585-x","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:03:24Z","timestamp":1791968604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Levetiracetam restores GABAergic function and network homeostasis following Vps35 deficiency in excitatory neurons"],"prefix":"10.1186","volume":"15","author":[{"given":"Zhi-Peng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daehoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Cheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"585_CR1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1474043","volume":"11","author":"S Safiri","year":"2024","unstructured":"Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A, et al. Alzheimer\u2019s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. Front Med. 2024;11:1474043.","journal-title":"Front Med"},{"key":"585_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/JGP.0b013e3182051ab4","volume":"19","author":"M Ganguli","year":"2011","unstructured":"Ganguli M, Blacker D, Blazer DG, Grant I, Jeste DV, Paulsen JS, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry. 2011;19:205\u201310.","journal-title":"Am J Geriatr Psychiatry"},{"key":"585_CR3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/13803395.2024.2410207","volume":"46","author":"LA Grebe","year":"2024","unstructured":"Grebe LA, Vonk JMJ, Galletta EE, Goral M. Cognitive reserve in individuals with frontotemporal dementia: a systematic review. J Clin Exp Neuropsychol. 2024;46:718\u201341.","journal-title":"J Clin Exp Neuropsychol"},{"key":"585_CR4","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","volume":"73","author":"C Iadecola","year":"2019","unstructured":"Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA, et al. Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol. 2019;73:3326\u201344.","journal-title":"J Am Coll Cardiol"},{"key":"585_CR5","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2022.101441","volume":"69","author":"S Prasad","year":"2023","unstructured":"Prasad S, Katta MR, Abhishek S, Sridhar R, Valisekka SS, Hameed M, et al. Recent advances in Lewy body dementia: a comprehensive review. Dis Mon. 2023;69:101441.","journal-title":"Dis Mon"},{"key":"585_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer Disease pathogenesis. JAMA Neurol. 2014;71:505.","journal-title":"JAMA Neurol"},{"key":"585_CR7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012;71:362\u201381.","journal-title":"J Neuropathol Exp Neurol"},{"key":"585_CR8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl DP. Neuropathology of Alzheimer\u2019s disease. Mt Sinai J Med. 2010;77:32\u201342.","journal-title":"Mt Sinai J Med"},{"key":"585_CR9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130\u20133.","journal-title":"Science"},{"key":"585_CR10","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM-Y, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology. 2000;54:1916\u201321.","journal-title":"Neurology."},{"key":"585_CR11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0022-510X(92)90047-O","volume":"108","author":"T Mizutani","year":"1992","unstructured":"Mizutani T, Shimada H. Neuropathological background of twenty-seven centenarian brains. J Neurol Sci. 1992;108:168\u201377.","journal-title":"J Neurol Sci"},{"key":"585_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1474-9726.2007.00289.x","volume":"6","author":"DL Dickstein","year":"2007","unstructured":"Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. Changes in the structural complexity of the aged brain. Aging Cell. 2007;6:275\u201384.","journal-title":"Aging Cell"},{"key":"585_CR13","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1038\/s41467-021-22742-8","volume":"12","author":"JC Lauterborn","year":"2021","unstructured":"Lauterborn JC, Scaduto P, Cox CD, Schulmann A, Lynch G, Gall CM, et al. Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer\u2019s disease. Nat Commun. 2021;12:2603.","journal-title":"Nat Commun"},{"key":"585_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-022-02526-0","volume":"145","author":"P Scaduto","year":"2023","unstructured":"Scaduto P, Lauterborn JC, Cox CD, Fracassi A, Zeppillo T, Gutierrez BA, et al. Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer\u2019s disease neuropathologic change. Acta Neuropathol. 2023;145:303\u201324.","journal-title":"Acta Neuropathol"},{"key":"585_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111946","volume":"42","author":"S Niraula","year":"2023","unstructured":"Niraula S, Doderer JJ, Indulkar S, Berry KP, Hauser WL, L\u2019Esperance OJ, et al. Excitation-inhibition imbalance disrupts visual familiarity in amyloid and non-pathology conditions. Cell Rep. 2023;42:111946.","journal-title":"Cell Rep"},{"key":"585_CR16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1535370221989263","volume":"246","author":"SM Sears","year":"2021","unstructured":"Sears SM, Hewett SJ. Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance. Exp Biol Med (Maywood). 2021;246:1069\u201383.","journal-title":"Exp Biol Med (Maywood)"},{"key":"585_CR17","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/ene.15043","volume":"29","author":"H Kurucu","year":"2022","unstructured":"Kurucu H, Colom\u2010Cadena M, Davies C, Wilkins L, King D, Rose J, et al. Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer\u2019s disease. Eur J Neurol. 2022;29:1311\u201323.","journal-title":"Eur J Neurol"},{"key":"585_CR18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77850","volume":"11","author":"KG Ranasinghe","year":"2022","unstructured":"Ranasinghe KG, Verma P, Cai C, Xie X, Kudo K, Gao X, et al. Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer\u2019s disease. Elife. 2022;11:e77850.","journal-title":"Elife"},{"key":"585_CR19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","volume":"70","author":"KA Vossel","year":"2013","unstructured":"Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013;70:1158.","journal-title":"JAMA Neurol"},{"key":"585_CR20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm.4330","volume":"23","author":"AD Lam","year":"2017","unstructured":"Lam AD, Deck G, Goldman A, Eskandar EN, Noebels J, Cole AJ. Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer\u2019s disease. Nat Med. 2017;23:678\u201380.","journal-title":"Nat Med"},{"key":"585_CR21","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1523\/JNEUROSCI.2250-06.2006","volume":"26","author":"KA Celone","year":"2006","unstructured":"Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer\u2019s disease: an independent component analysis. J Neurosci. 2006;26:10222\u201331.","journal-title":"J Neurosci"},{"key":"585_CR22","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jmri.28469","volume":"57","author":"F Mohammadian","year":"2023","unstructured":"Mohammadian F, Zare Sadeghi A, Noroozian M, Malekian V, Abbasi Sisara M, Hashemi H, et al. Quantitative assessment of resting-state functional connectivity MRI to differentiate amnestic mild cognitive impairment, late-onset Alzheimer\u2019s disease from normal subjects. Magn Reson Imaging. 2023;57:1702\u201312.","journal-title":"Magn Reson Imaging"},{"key":"585_CR23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biopsych.2012.11.028","volume":"74","author":"YI Sheline","year":"2013","unstructured":"Sheline YI, Raichle ME. Resting state functional connectivity in preclinical Alzheimer\u2019s disease. Biol Psychiatry. 2013;74:340\u20137.","journal-title":"Biol Psychiatry"},{"key":"585_CR24","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold K-H, Haass C, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science. 2008;321:1686\u20139.","journal-title":"Science"},{"key":"585_CR25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret L, Mann EO, Hang GB, Barth AMI, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149:708\u201321.","journal-title":"Cell"},{"key":"585_CR26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50333","volume":"8","author":"S Ghatak","year":"2019","unstructured":"Ghatak S, Dolatabadi N, Trudler D, Zhang X, Wu Y, Mohata M, et al. Mechanisms of hyperexcitability in Alzheimer\u2019s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls. Elife. 2019;8:e50333.","journal-title":"Elife"},{"key":"585_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","volume":"17","author":"E Cumbo","year":"2010","unstructured":"Cumbo E, Ligori LD. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease. Epilepsy Behav. 2010;17:461\u20136.","journal-title":"Epilepsy Behav"},{"issue":"42","key":"585_CR28","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci U S A. 2012;109(42):E2895\u2013903.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"585_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/psyg.12085","volume":"15","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Gen K. Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer\u2019s disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial. Psychogeriatrics. 2015;15:32\u20137.","journal-title":"Psychogeriatrics"},{"key":"585_CR30","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106106","volume":"181","author":"E Rizzello","year":"2023","unstructured":"Rizzello E, Pimpinella D, Pignataro A, Titta G, Merenda E, Saviana M, et al. Lamotrigine rescues neuronal alterations and prevents seizure-induced memory decline in an Alzheimer\u2019s disease mouse model. Neurobiol Dis. 2023;181:106106.","journal-title":"Neurobiol Dis"},{"key":"585_CR31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0883073818811511","volume":"34","author":"D Nolan","year":"2019","unstructured":"Nolan D, Lester SG, Rau SM, Shellhaas RA. Clinical use and efficacy of levetiracetam for absence epilepsies. J Child Neurol. 2019;34:94\u20138.","journal-title":"J Child Neurol"},{"key":"585_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrn811","volume":"3","author":"V Crunelli","year":"2002","unstructured":"Crunelli V, Leresche N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci. 2002;3:371\u201382.","journal-title":"Nat Rev Neurosci"},{"key":"585_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41582-024-00932-4","volume":"20","author":"A Kamondi","year":"2024","unstructured":"Kamondi A, Grigg-Damberger M, L\u00f6scher W, Tanila H, Horvath AA. Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums. Nat Rev Neurol. 2024;20:162\u201382.","journal-title":"Nat Rev Neurol"},{"issue":"16","key":"585_CR34","first-page":"e2259","volume":"95","author":"AD Lam","year":"2020","unstructured":"Lam AD, Sarkis RA, Pellerin KR, Jing J, Dworetzky BA, Hoch DB, et al. Association of epileptiform abnormalities and seizures in Alzheimer disease. Neurology. 2020;95(16):e2259\u201370.","journal-title":"Neurology"},{"key":"585_CR35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.200312034","volume":"165","author":"MNJ Seaman","year":"2004","unstructured":"Seaman MNJ. Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J Cell Biol. 2004;165:111\u201322.","journal-title":"J Cell Biol"},{"key":"585_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ncb2374","volume":"14","author":"PJ Cullen","year":"2012","unstructured":"Cullen PJ, Korswagen HC. Sorting nexins provide diversity for retromer-dependent trafficking events. Nat Cell Biol. 2012;14:29\u201337.","journal-title":"Nat Cell Biol"},{"key":"585_CR37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.20667","volume":"58","author":"SA Small","year":"2005","unstructured":"Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, et al. Model\u2010guided microarray implicates the retromer complex in Alzheimer\u2019s disease. Ann Neurol. 2005;58:909\u201319.","journal-title":"Ann Neurol"},{"key":"585_CR38","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.celrep.2015.08.001","volume":"12","author":"F-L Tang","year":"2015","unstructured":"Tang F-L, Liu W, Hu J-X, Erion JR, Ye J, Mei L, et al. VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function. Cell Rep. 2015;12:1631\u201343.","journal-title":"Cell Rep"},{"key":"585_CR39","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1073\/pnas.0802545105","volume":"105","author":"A Muhammad","year":"2008","unstructured":"Muhammad A, Flores I, Zhang H, Yu R, Staniszewski A, Planel E, et al. Retromer deficiency observed in Alzheimer\u2019s disease causes hippocampal dysfunction, neurodegeneration, and A\u03b2 accumulation. Proc Natl Acad Sci U S A. 2008;105:7327\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"585_CR40","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s41418-019-0487-2","volume":"27","author":"F-L Tang","year":"2020","unstructured":"Tang F-L, Zhao L, Zhao Y, Sun D, Zhu X-J, Mei L, et al. Coupling of terminal differentiation deficit with neurodegenerative pathology in Vps35-deficient pyramidal neurons. Cell Death Differ. 2020;27:2099\u2013116.","journal-title":"Cell Death Differ"},{"key":"585_CR41","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1038\/ncomms4828","volume":"5","author":"E Zavodszky","year":"2014","unstructured":"Zavodszky E, Seaman MNJ, Moreau K, Jimenez-Sanchez M, Breusegem SY, Harbour ME, et al. Mutation in VPS35 associated with Parkinson\u2019s disease impairs WASH complex association and inhibits autophagy. Nat Commun. 2014;5:3828.","journal-title":"Nat Commun"},{"key":"585_CR42","volume":"8","author":"ME Curtis","year":"2022","unstructured":"Curtis ME, Smith T, Blass BE, Pratic\u00f2 D. Dysfunction of the retromer complex system contributes to amyloid and tau pathology in a stem cell model of Down syndrome. Alzheimers Dement (N Y). 2022;8:e12334.","journal-title":"Alzheimers Dement (N Y)"},{"key":"585_CR43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","volume":"89","author":"C Vilari\u00f1o-G\u00fcell","year":"2011","unstructured":"Vilari\u00f1o-G\u00fcell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011;89:162\u20137.","journal-title":"Am J Hum Genet"},{"key":"585_CR44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","volume":"89","author":"A Zimprich","year":"2011","unstructured":"Zimprich A, Benet-Pag\u00e8s A, Struhal W, Graf E, Eck SH, Offman MN, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011;89:168\u201375.","journal-title":"Am J Hum Genet"},{"key":"585_CR45","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/archneurol.2011.3367","volume":"69","author":"KR Kumar","year":"2012","unstructured":"Kumar KR, Weissbach A, Heldmann M, Kasten M, Tunc S, Sue CM, et al. Frequency of the D620N mutation in VPS35 in Parkinson disease. Arch Neurol. 2012;69:1360.","journal-title":"Arch Neurol"},{"key":"585_CR46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1083\/jcb.201105109","volume":"195","author":"L Wen","year":"2011","unstructured":"Wen L, Tang FL, Hong Y, Luo SW, Wang CL, He W, et al. VPS35 haploinsufficiency increases Alzheimer\u2019s disease neuropathology. J Cell Biol. 2011;195:765\u201379.","journal-title":"J Cell Biol"},{"key":"585_CR47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2012.03.030","volume":"47","author":"A Bhalla","year":"2012","unstructured":"Bhalla A, Vetanovetz CP, Morel E, Chamoun Z, Di Paolo G, Small SA. The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport. Neurobiol Dis. 2012;47:126\u201334.","journal-title":"Neurobiol Dis"},{"key":"585_CR48","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/tra.12451","volume":"17","author":"J Yin","year":"2016","unstructured":"Yin J, Liu X, He Q, Zhou L, Yuan Z, Zhao S. Vps35\u2010dependent recycling of Trem2 regulates microglial function. Traffic. 2016;17:1286\u201396.","journal-title":"Traffic"},{"key":"585_CR49","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1523\/JNEUROSCI.2272-11.2012","volume":"32","author":"AW Fjorback","year":"2012","unstructured":"Fjorback AW, Seaman M, Gustafsen C, Mehmedbasic A, Gokool S, Wu C, et al. Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing. J Neurosci. 2012;32:1467\u201380.","journal-title":"J Neurosci"},{"key":"585_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02422-0","volume":"19","author":"X Ren","year":"2022","unstructured":"Ren X, Yao L, Wang Y, Mei L, Xiong WC. Microglial VPS35 deficiency impairs A\u03b2 phagocytosis and A\u03b2-induced disease-associated microglia, and enhances A\u03b2 associated pathology. J Neuroinflammation. 2022;19:61.","journal-title":"J Neuroinflammation"},{"key":"585_CR51","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","volume":"68","author":"F Hu","year":"2010","unstructured":"Hu F, Padukkavidana T, V\u00e6gter CB, Brady OA, Zheng Y, Mackenzie IR, et al. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron. 2010;68:654\u201367.","journal-title":"Neuron"},{"key":"585_CR52","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1242\/bio.20122451","volume":"1","author":"CL Wang","year":"2012","unstructured":"Wang CL, Tang FL, Peng Y, Shen CY, Mei L, Xiong WC. VPS35 regulates developing mouse hippocampal neuronal morphogenesis by promoting retrograde trafficking of BACE1. Biol Open. 2012;1:1248\u201357.","journal-title":"Biol Open"},{"key":"585_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-015-0156-4","volume":"8","author":"Y Tian","year":"2015","unstructured":"Tian Y, Tang F-L, Sun X, Wen L, Mei L, Tang B-S, et al. VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation. Mol Brain. 2015;8:70.","journal-title":"Mol Brain"},{"key":"585_CR54","volume":"10","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Lee D, Zhu XJ, Xiong WC. Critical role of neuronal Vps35 in blood vessel branching and maturation in developing mouse brain. Biomedicines. 2022;10:1653.","journal-title":"Biomedicines"},{"key":"585_CR55","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1523\/JNEUROSCI.3621-17.2018","volume":"38","author":"JR Appel","year":"2018","unstructured":"Appel JR, Ye S, Tang F, Sun D, Zhang H, Mei L, et al. Increased microglial activity, impaired adult hippocampal neurogenesis, and depressive-like behavior in microglial VPS35-depleted mice. J Neurosci. 2018;38:5949\u201368.","journal-title":"J Neurosci"},{"key":"585_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41596-018-0097-3","volume":"14","author":"RC Challis","year":"2019","unstructured":"Challis RC, Ravindra Kumar S, Chan KY, Challis C, Beadle K, Jang MJ, et al. Systemic AAV vectors for widespread and targeted gene delivery in rodents. Nat Protoc. 2019;14:379\u2013414.","journal-title":"Nat Protoc"},{"key":"585_CR57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41418-025-01581-w","volume":"33","author":"D Lee","year":"2026","unstructured":"Lee D, Wu A, Yao L, Satish S, Mei L, Xiong WC. Neuronal MCT2 promotes angiogenesis via lactate in the developing mouse neocortex. Cell Death Differ. 2026;33:539\u201356.","journal-title":"Cell Death Differ"},{"key":"585_CR58","doi-asserted-by":"crossref","first-page":"e1291232024","DOI":"10.1523\/JNEUROSCI.1291-23.2024","volume":"44","author":"M Delhaye","year":"2024","unstructured":"Delhaye M, LeDue J, Robinson K, Xu Q, Zhang Q, Oku S, et al. Adaptation of magnified analysis of the proteome for excitatory synaptic proteins in varied samples and evaluation of cell type-specific distributions. J Neurosci. 2024;44:e1291232024.","journal-title":"J Neurosci"},{"key":"585_CR59","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nbt.3641","volume":"34","author":"T Ku","year":"2016","unstructured":"Ku T, Swaney J, Park JY, Albanese A, Murray E, Cho JH, et al. Multiplexed and scalable super-resolution imaging of three-dimensional protein localization in size-adjustable tissues. Nat Biotechnol. 2016;34:973\u201381.","journal-title":"Nat Biotechnol"},{"key":"585_CR60","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1523\/JNEUROSCI.0247-23.2023","volume":"43","author":"N Gao","year":"2023","unstructured":"Gao N, Liu Z, Wang H, Shen C, Dong Z, Cui W, et al. Deficiency of cullin 3, a protein encoded by a schizophrenia and autism risk gene, impairs behaviors by enhancing the excitability of ventral tegmental area (VTA) DA neurons. J Neurosci. 2023;43:6249\u201367.","journal-title":"J Neurosci"},{"key":"585_CR61","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neuron.2019.10.035","volume":"105","author":"Z Dong","year":"2020","unstructured":"Dong Z, Chen W, Chen C, Wang H, Cui W, Tan Z, et al. CUL3 deficiency causes social deficits and anxiety-like behaviors by impairing excitation-inhibition balance through the promotion of cap-dependent translation. Neuron. 2020;105:475-490.e6.","journal-title":"Neuron"},{"key":"585_CR62","doi-asserted-by":"crossref","unstructured":"Denninger JK, Smith BM, Kirby ED. Novel object recognition and object location behavioral testing in mice on a budget. J Vis Exp. 2018;58593.","DOI":"10.3791\/58593-v"},{"key":"585_CR63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47\u201360.","journal-title":"J Neurosci Methods"},{"key":"585_CR64","volume":"4","author":"D Lee","year":"2019","unstructured":"Lee D, Krishnan B, Zhang H, Park HR, Ro EJ, Jung YN, et al. Activity of hippocampal adult-born neurons regulates alcohol withdrawal seizures. JCI Insight. 2019;4:e128770.","journal-title":"JCI Insight"},{"key":"585_CR65","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2018.03.018","volume":"98","author":"Z Tan","year":"2018","unstructured":"Tan Z, Robinson HL, Yin DM, Liu Y, Liu F, Wang H, et al. Dynamic ErbB4 activity in hippocampal-prefrontal synchrony and top-down attention in rodents. Neuron. 2018;98:380-393.e4.","journal-title":"Neuron"},{"key":"585_CR66","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nn.4326","volume":"19","author":"XD Sun","year":"2016","unstructured":"Sun XD, Li L, Liu F, Huang ZH, Bean JC, Jiao HF, et al. Lrp4 in astrocytes modulates glutamatergic transmission. Nat Neurosci. 2016;19:1010\u20138.","journal-title":"Nat Neurosci"},{"key":"585_CR67","doi-asserted-by":"crossref","first-page":"23818","DOI":"10.1074\/jbc.M701078200","volume":"282","author":"IH Cheng","year":"2007","unstructured":"Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, et al. Accelerating amyloid-\u03b2 fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem. 2007;282:23818\u201328.","journal-title":"J Biol Chem"},{"key":"585_CR68","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nature05289","volume":"443","author":"JJ Palop","year":"2006","unstructured":"Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature. 2006;443:768\u201373.","journal-title":"Nature"},{"key":"585_CR69","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/bies.201500004","volume":"37","author":"MA Busche","year":"2015","unstructured":"Busche MA, Konnerth A. Neuronal hyperactivity\u2014a key defect in Alzheimer\u2019s disease? BioEssays. 2015;37:624\u201332.","journal-title":"BioEssays"},{"key":"585_CR70","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1073\/pnas.0802908105","volume":"105","author":"F Cacucci","year":"2008","unstructured":"Cacucci F, Yi M, Wills TJ, Chapman P, O\u2019Keefe J. Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model. Proc Natl Acad Sci USA. 2008;105:7863\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"585_CR71","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.neuron.2020.06.023","volume":"107","author":"H Jun","year":"2020","unstructured":"Jun H, Bramian A, Soma S, Saito T, Saido TC, Igarashi KM. Disrupted place cell remapping and impaired grid cells in a knockin model of Alzheimer\u2019s disease. Neuron. 2020;107:1095-1112.e6.","journal-title":"Neuron"},{"key":"585_CR72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s Disease. Neuron. 2007;55:697\u2013711.","journal-title":"Neuron"},{"key":"585_CR73","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrn2286","volume":"9","author":"N Spruston","year":"2008","unstructured":"Spruston N. Pyramidal neurons: dendritic structure and synaptic integration. Nat Rev Neurosci. 2008;9:206\u201321.","journal-title":"Nat Rev Neurosci"},{"key":"585_CR74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12975-013-0297-7","volume":"5","author":"NH Shah","year":"2014","unstructured":"Shah NH, Aizenman E. Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration. Transl Stroke Res. 2014;5:38\u201358.","journal-title":"Transl Stroke Res"},{"key":"585_CR75","volume":"8","author":"E Akyuz","year":"2020","unstructured":"Akyuz E, Villa C, Beker M, Elibol B. Unraveling the role of inwardly rectifying potassium channels in the hippocampus of an A\u03b2(1\u201342)-infused rat model of Alzheimer\u2019s Disease. Biomedicines. 2020;8:58.","journal-title":"Biomedicines"},{"key":"585_CR76","doi-asserted-by":"crossref","first-page":"796136","DOI":"10.3389\/fcell.2021.796136","volume":"9","author":"NA Hager","year":"2022","unstructured":"Hager NA, McAtee CK, Lesko MA, O\u2019Donnell AF. Inwardly rectifying potassium channel Kir2.1 and its \u201cKir-ious\u201d regulation by protein trafficking and roles in development and disease. Front Cell Dev Biol. 2022;9:796136.","journal-title":"Front Cell Dev Biol."},{"key":"585_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature10360","volume":"477","author":"O Yizhar","year":"2011","unstructured":"Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O\u2019Shea DJ, et al. Neocortical excitation\/inhibition balance in information processing and social dysfunction. Nature. 2011;477:171\u20138.","journal-title":"Nature"},{"key":"585_CR78","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1211095","volume":"334","author":"TP Vogels","year":"2011","unstructured":"Vogels TP, Sprekeler H, Zenke F, Clopath C, Gerstner W. Inhibitory plasticity balances excitation and inhibition in sensory pathways and memory networks. Science. 2011;334:1569\u201373.","journal-title":"Science"},{"key":"585_CR79","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1523\/JNEUROSCI.09-08-02982.1989","volume":"9","author":"K Harris","year":"1989","unstructured":"Harris K, Stevens J. Dendritic spines of CA 1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics. J Neurosci. 1989;9:2982\u201397.","journal-title":"J Neurosci"},{"key":"585_CR80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TVP Bliss","year":"1993","unstructured":"Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361:31\u20139.","journal-title":"Nature"},{"key":"585_CR81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","volume":"44","author":"RC Malenka","year":"2004","unstructured":"Malenka RC, Bear MF. LTP and LTD. Neuron. 2004;44:5\u201321.","journal-title":"Neuron"},{"key":"585_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/6374","volume":"2","author":"PF Chapman","year":"1999","unstructured":"Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci. 1999;2:271\u20136.","journal-title":"Nat Neurosci"},{"key":"585_CR83","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/BST0330563","volume":"33","author":"MJ Rowan","year":"2005","unstructured":"Rowan MJ, Klyubin I, Wang Q, Anwyl R. Synaptic plasticity disruption by amyloid \u03b2 protein: modulation by potential Alzheimer\u2019s disease modifying therapies. Biochem Soc Trans. 2005;33:563\u20137.","journal-title":"Biochem Soc Trans"},{"key":"585_CR84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","volume":"74","author":"A Bakker","year":"2012","unstructured":"Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74:467\u201374.","journal-title":"Neuron"},{"key":"585_CR85","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004;101:9861\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"585_CR86","doi-asserted-by":"crossref","DOI":"10.1016\/j.aspetd.2025.100006","volume":"1","author":"AN Ewens","year":"2025","unstructured":"Ewens AN, Thayer SA. Levetiracetam: an antiseizure drug with unique neuroprotective properties. ASPET Discovery. 2025;1:100006.","journal-title":"ASPET Discovery"},{"key":"585_CR87","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","volume":"96","author":"KM Crowder","year":"1999","unstructured":"Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A. 1999;96:15268\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"585_CR88","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/mol.111.076687","volume":"82","author":"C Vogl","year":"2012","unstructured":"Vogl C, Mochida S, Wolff C, Whalley BJ, Stephens GJ. The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway. Mol Pharmacol. 2012;82:199\u2013208.","journal-title":"Mol Pharmacol"},{"key":"585_CR89","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1023\/A:1008925309027","volume":"8","author":"N Brunel","year":"2000","unstructured":"Brunel N. Dynamics of sparsely connected networks of excitatory and inhibitory spiking neurons. J Comput Neurosci. 2000;8:183\u2013208.","journal-title":"J Comput Neurosci"},{"key":"585_CR90","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrn1949","volume":"7","author":"E Marder","year":"2006","unstructured":"Marder E, Goaillard J-M. Variability, compensation and homeostasis in neuron and network function. Nat Rev Neurosci. 2006;7:563\u201374.","journal-title":"Nat Rev Neurosci"},{"key":"585_CR91","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1523\/JNEUROSCI.0413-20.2020","volume":"40","author":"AQ Nguyen","year":"2020","unstructured":"Nguyen AQ, Sutley S, Koeppen J, Mina K, Woodruff S, Hanna S, et al. Astrocytic ephrin-B1 controls excitatory-inhibitory balance in developing hippocampus. J Neurosci. 2020;40:6854\u201371.","journal-title":"J Neurosci"},{"key":"585_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-024-01151-0","volume":"17","author":"J-H Tao-Cheng","year":"2024","unstructured":"Tao-Cheng J-H, Moreira SL, Winters CA. Ultrastructural characterization of hippocampal inhibitory synapses under resting and stimulated conditions. Mol Brain. 2024;17:76.","journal-title":"Mol Brain"},{"key":"585_CR93","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuron.2017.03.020","volume":"94","author":"P Temkin","year":"2017","unstructured":"Temkin P, Morishita W, Goswami D, Arendt K, Chen L, Malenka R. The retromer supports AMPA receptor trafficking during LTP. Neuron. 2017;94:74-82.e5.","journal-title":"Neuron"},{"key":"585_CR94","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.1260088","volume":"347","author":"F Chen","year":"2015","unstructured":"Chen F, Tillberg PW, Boyden ES. Expansion microscopy. Science. 2015;347:543\u20138.","journal-title":"Science"},{"key":"585_CR95","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nbt.3625","volume":"34","author":"PW Tillberg","year":"2016","unstructured":"Tillberg PW, Chen F, Piatkevich KD, Zhao Y, Yu C-C, English BP, et al. Protein-retention expansion microscopy of cells and tissues labeled using standard fluorescent proteins and antibodies. Nat Biotechnol. 2016;34:987\u201392.","journal-title":"Nat Biotechnol"},{"key":"585_CR96","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nbt.4281","volume":"37","author":"Y-G Park","year":"2019","unstructured":"Park Y-G, Sohn CH, Chen R, McCue M, Yun DH, Drummond GT, et al. Protection of tissue physicochemical properties using polyfunctional crosslinkers. Nat Biotechnol. 2019;37:73\u201383.","journal-title":"Nat Biotechnol"},{"key":"585_CR97","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrn3670","volume":"15","author":"SK Tyagarajan","year":"2014","unstructured":"Tyagarajan SK, Fritschy JM. Gephyrin: a master regulator of neuronal function? Nat Rev Neurosci. 2014;15:141\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"585_CR98","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1523\/JNEUROSCI.1661-03.2004","volume":"24","author":"S L\u00e9vi","year":"2004","unstructured":"L\u00e9vi S, Logan SM, Tovar KR, Craig AM. Gephyrin is critical for glycine receptor clustering but not for the formation of functional GABAergic synapses in hippocampal neurons. J Neurosci. 2004;24:207\u201317.","journal-title":"J Neurosci"},{"key":"585_CR99","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1523\/JNEUROSCI.0669-17.2018","volume":"38","author":"TW Lin","year":"2018","unstructured":"Lin TW, Tan Z, Barik A, Yin D-M, Brudvik E, Wang H, et al. Regulation of synapse development by Vgat deletion from ErbB4-positive interneurons. J Neurosci. 2018;38:2533\u201350.","journal-title":"J Neurosci"},{"key":"585_CR100","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1523\/JNEUROSCI.18-23-09733.1998","volume":"18","author":"FA Chaudhry","year":"1998","unstructured":"Chaudhry FA, Reimer RJ, Bellocchio EE, Danbolt NC, Osen KK, Edwards RH, et al. The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci. 1998;18:9733\u201350.","journal-title":"J Neurosci"},{"key":"585_CR101","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1523\/JNEUROSCI.20-13-04904.2000","volume":"20","author":"S Takamori","year":"2000","unstructured":"Takamori S, Riedel D, Jahn R. Immunoisolation of GABA-specific synaptic vesicles defines a functionally distinct subset of synaptic vesicles. J Neurosci. 2000;20:4904\u201311.","journal-title":"J Neurosci"},{"key":"585_CR102","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1016\/j.cell.2023.09.028","volume":"186","author":"M Van Oostrum","year":"2023","unstructured":"Van Oostrum M, Blok TM, Giandomenico SL, Tom Dieck S, Tushev G, F\u00fcrst N, et al. The proteomic landscape of synaptic diversity across brain regions and cell types. Cell. 2023;186:5411-5427.e23.","journal-title":"Cell"},{"key":"585_CR103","doi-asserted-by":"crossref","first-page":"fcad302","DOI":"10.1093\/braincomms\/fcad302","volume":"5","author":"R Ciliento","year":"2023","unstructured":"Ciliento R, Gjini K, Dabbs K, Hermann B, Riedner B, Jones S, et al. Prevalence and localization of nocturnal epileptiform discharges in mild cognitive impairment. Brain Commun. 2023;5:fcad302.","journal-title":"Brain Commun."},{"key":"585_CR104","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.clinph.2020.02.015","volume":"131","author":"V Brunetti","year":"2020","unstructured":"Brunetti V, D\u2019Atri A, Della Marca G, Vollono C, Marra C, Vita MG, et al. Subclinical epileptiform activity during sleep in Alzheimer\u2019s disease and mild cognitive impairment. Clin Neurophysiol. 2020;131:1011\u20138.","journal-title":"Clin Neurophysiol"},{"key":"585_CR105","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.celrep.2019.10.096","volume":"29","author":"EF Halff","year":"2019","unstructured":"Halff EF, Szulc BR, Lesept F, Kittler JT. SNX27-mediated recycling of neuroligin-2 regulates inhibitory signaling. Cell Rep. 2019;29:2599-2607.e6.","journal-title":"Cell Rep"},{"key":"585_CR106","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2009.08.023","volume":"63","author":"A Poulopoulos","year":"2009","unstructured":"Poulopoulos A, Aramuni G, Meyer G, Soykan T, Hoon M, Papadopoulos T, et al. Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron. 2009;63:628\u201342.","journal-title":"Neuron"},{"key":"585_CR107","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2017.10.024","volume":"171","author":"TC S\u00fcdhof","year":"2017","unstructured":"S\u00fcdhof TC. Synaptic neurexin complexes: a molecular code for the logic of neural circuits. Cell. 2017;171:745\u201369.","journal-title":"Cell"},{"key":"585_CR108","volume":"18","author":"Y Sui","year":"2024","unstructured":"Sui Y, Mortensen M, Yuan B, Nicholson MW, Smart TG, Jovanovic JN. GABAA receptors and neuroligin 2 synergize to promote synaptic adhesion and inhibitory synaptogenesis. Front Cell Neurosci. 2024;18:1423471.","journal-title":"Front Cell Neurosci"},{"key":"585_CR109","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1007\/s00429-017-1462-7","volume":"222","author":"P Panzanelli","year":"2017","unstructured":"Panzanelli P, Fr\u00fch S, Fritschy J-M. Differential role of GABAA receptors and neuroligin 2 for perisomatic GABAergic synapse formation in the hippocampus. Brain Struct Funct. 2017;222:4149\u201361.","journal-title":"Brain Struct Funct"},{"key":"585_CR110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2018.02.029","volume":"98","author":"M Martinez-Losa","year":"2018","unstructured":"Martinez-Losa M, Tracy TE, Ma K, Verret L, Clemente-Perez A, Khan AS, et al. Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer\u2019s disease. Neuron. 2018;98:75-89.e5.","journal-title":"Neuron"},{"key":"585_CR111","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1093\/brain\/awad250","volume":"146","author":"I Keramidis","year":"2023","unstructured":"Keramidis I, McAllister BB, Bourbonnais J, Wang F, Isabel D, Rezaei E, et al. Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer\u2019s disease mutations. Brain. 2023;146:4903\u201315.","journal-title":"Brain"},{"key":"585_CR112","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1081657","volume":"16","author":"A Kreis","year":"2023","unstructured":"Kreis A, Issa F, Yerna X, Jabbour C, Schakman O, De Clippele M, et al. Conditional deletion of KCC2 impairs synaptic plasticity and both spatial and nonspatial memory. Front Mol Neurosci. 2023;16:1081657.","journal-title":"Front Mol Neurosci"},{"key":"585_CR113","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","volume":"78","author":"K Vossel","year":"2021","unstructured":"Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, et al. Effect of levetiracetam on cognition in patients with Alzheimer Disease with and without epileptiform activity: a randomized clinical trial. JAMA Neurol. 2021;78:1345.","journal-title":"JAMA Neurol"},{"key":"585_CR114","volume":"8","author":"KD Onos","year":"2022","unstructured":"Onos KD, Quinney SK, Jones DR, Masters AR, Pandey R, Keezer KJ, et al. Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: a MODEL-AD preclinical testing core study. Alzheimers Dement (N Y). 2022;8:e12329.","journal-title":"Alzheimers Dement (N Y)"},{"key":"585_CR115","volume":"194","author":"JR Bae","year":"2020","unstructured":"Bae JR, Lee W, Jo YO, Han S, Koh S, Song WK, et al. Distinct synaptic vesicle recycling in inhibitory nerve terminals is coordinated by SV2A. Prog Neurobiol. 2020;194:101879.","journal-title":"Prog Neurobiol"},{"key":"585_CR116","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11050531","volume":"11","author":"IJ Contreras-Garc\u00eda","year":"2021","unstructured":"Contreras-Garc\u00eda IJ, G\u00f3mez-Lira G, Phillips-Farf\u00e1n BV, Pichardo-Mac\u00edas LA, Garc\u00eda-Cruz ME, Ch\u00e1vez-Pacheco JL, et al. Synaptic vesicle protein 2A expression in glutamatergic terminals is associated with the response to levetiracetam treatment. Brain Sci. 2021;11:531.","journal-title":"Brain Sci"},{"key":"585_CR117","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1021\/acs.jproteome.1c00180","volume":"20","author":"NR Rao","year":"2021","unstructured":"Rao NR, Savas JN. Levetiracetam treatment normalizes levels of presynaptic endocytosis machinery and restores nonamyloidogenic APP processing in App knock-in mice. J Proteome Res. 2021;20:3580\u20139.","journal-title":"J Proteome Res"},{"key":"585_CR118","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nbd.2011.04.002","volume":"43","author":"CP Sullivan","year":"2011","unstructured":"Sullivan CP, Jay AG, Stack EC, Pakaluk M, Wadlinger E, Fine RE, et al. Retromer disruption promotes amyloidogenic APP processing. Neurobiol Dis. 2011;43:338\u201345.","journal-title":"Neurobiol Dis"},{"key":"585_CR119","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1523\/JNEUROSCI.0042-15.2015","volume":"35","author":"FL Tang","year":"2015","unstructured":"Tang FL, Erion JR, Tian Y, Liu W, Yin D-M, Ye J, et al. VPS35 in dopamine neurons is required for endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for \u03b1-synuclein degradation and prevention of pathogenesis of Parkinson\u2019s Disease. J Neurosci. 2015;35:10613\u201328.","journal-title":"J Neurosci"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00585-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00585-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00585-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:10:52Z","timestamp":1792012252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00585-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00585-x","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal, including live animal, experiments were conducted in accordance with the guidelines of the Animal Resource Center (ARC) and approved by the Institutional Animal Care and Use Committee (IACUC) at Case Western Reserve University (approval nos. 2017-0121, 2017-0115). The program is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"54"}}